News
It’s amazing how many ways you can send money to your friends. I still remember when PayPal PYPL was the only way, but nowadays,...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow Yiannis Zourmpanos, founder of Yiazou IQ, an AI-driven stock research platform providing all-in-one stock reports. Experience: Previously worked...
News
This article was written by Follow Samuel Smith has a diverse background that includes being lead analyst and Vice President at several highly regarded...
News
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish...
News
Ardmore Shipping Corporation (NYSE:ASC) recently noted a transformation phase that included the optimization of the schedules of its ships and the reduction in fuel...
News
A few weeks ago, I wrote a cautious article on the Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust (GBAB), arguing investors should...
News
What businesses underpin our world? What businesses make a compelling case for investment? Depending on who you ask, everyone has a different answer. The...
News
Soft landing? Not so fast. The triple threat of rising interest rates, oil prices, and the US dollar is the result of the ubiquitous...
News
BTI and Ray Dalio’s grand scheme of investing The goals of this article are twofold. First, I want to share the key insights I’ve...
News
Medical Equipment is a large market where disruptive technology that provides lower costs creates competition and progress. Nano-X Imaging Ltd. (NASDAQ:NNOX) is a company...
News
For the first time in several months, I’m seeing some bargains beginning to appear in the market. Of course, I’m more conservative with purchases...
News
Written by Nick Ackerman. Real estate investment trusts (“REITs”) have been getting hit hard by higher yields as the Fed ramped up interest rates....
News
Reason for the update: New clinical data readout The most recent clinical data from NewAmsterdam Pharma (NASDAQ:NAMS) has showcased the potential of obicetrapib in...
